Two Sigma Advisers’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-127,304
| Closed | -$7.09M | – | 2524 |
|
|
2018
Q4 | $7.09M | Sell |
127,304
-164,500
| -56% | -$8.93M | 0.02% | 671 |
|
|
2018
Q3 | $13.6M | Sell |
291,804
-7,500
| -3% | -$363K | 0.03% | 498 |
|
|
2018
Q2 | $14.4M | Sell |
299,304
-7,700
| -3% | -$368K | 0.04% | 472 |
|
|
2018
Q1 | $13.3M | Sell |
307,004
-48,500
| -14% | -$2.18M | 0.04% | 496 |
|
|
2017
Q4 | $14.1M | Buy |
355,504
+37,400
| +12% | +$1.56M | 0.04% | 493 |
|
|
2017
Q3 | $13.8M | Sell |
318,104
-48,200
| -13% | -$2.2M | 0.04% | 473 |
|
|
2017
Q2 | $17.5M | Buy |
366,304
+199,800
| +120% | +$9.32M | 0.06% | 365 |
|
|
2017
Q1 | $6.83M | Buy |
166,504
+30,444
| +22% | +$1.27M | 0.02% | 691 |
|
|
2016
Q4 | $5.22M | Buy |
+136,060
| New | +$5.52M | 0.02% | 717 |
|
|
2016
Q1 | – | Sell |
-6,044
| Closed | -$383K | – | 2200 |
|
|
2015
Q4 | $383K | Buy |
6,044
+1,791
| +42% | +$122K | ﹤0.01% | 1426 |
|
|
2015
Q3 | $278K | Sell |
4,253
-5,100
| -55% | -$338K | ﹤0.01% | 1529 |
|
|
2015
Q2 | $633K | Buy |
+9,353
| New | +$516K | ﹤0.01% | 1333 |
|
Two Sigma Advisers's IMPV Position: Q1 2019 in Review
Two Sigma Advisers sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 127,304 shares — an estimated $7.09M sold.
Two Sigma Advisers first reported a position in IMPV in Q2 2015 and held it in 12 quarters. The position peaked at $17.5M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Two Sigma Advisers reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Two Sigma Advisers sold 127,304 Imperva, Inc. shares in Q1 2019, an estimated $7.09M.
- Two Sigma Advisers first reported a position in Imperva, Inc. in Q2 2015 and held it in 12 quarters.
- Two Sigma Advisers's Imperva, Inc. position peaked at $17.5M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Two Sigma Advisers's 13F filing for Q1 2019, filed 15 May 2019.